Literature DB >> 8922977

Expression of basement membrane type IV collagen chains during postnatal development in the murine cochlea.

D Cosgrove1, J M Kornak, G Samuelson.   

Abstract

An immunofluorescence study was performed to examine the temporal and spatial patterns of expression for the different type IV collagen chains during postnatal cochlear development. At birth, the classical chains (4A1 and 4A2) were widely expressed, while the novel chains (4A3, 4A4, and 4A5) were completely absent. Activation of the novel chains was observed at 4 days of age, with intense, widely distributed immunostaining suggesting that most of the cells in the cochlea express the novel chains at this developmental stage. From day 8 through day 14, developmental inactivation of the novel chains results in a reduction of generalized immunoreactivity with a concomitant elevation of specific staining in the membranous structures bounding the interdental cells of the spiral limbus, the inner sulcus, the basilar membrane, and in a fibrous bed of staining radiating from the spiral prominence into the region of the spiral ligament which corresponds to the location of the root cell processes. This pattern of intense immunostaining for the novel chains persists through adulthood. The classical chains are expressed in these same anatomical regions only transiently (from day 6 to day 10), after which a gradual developmental inactivation leads to the adult expression pattern where classical collagen chains are found primarily in the perineurium, in the membranes surrounding the spiral ganglion cell bodies, and in the vascular basement membranes of the spiral ligament and the stria vascularis. The complex developmental pattern of expression for the type IV collagen chains in the murine cochlea is similar to that observed in the murine kidney, which is the other major site for basement membrane pathology in Alport syndrome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8922977     DOI: 10.1016/0378-5955(96)00114-1

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  9 in total

1.  Type IV collagen is an activating ligand for the adhesion G protein-coupled receptor GPR126.

Authors:  Kevin J Paavola; Harwin Sidik; J Bradley Zuchero; Michael Eckart; William S Talbot
Journal:  Sci Signal       Date:  2014-08-12       Impact factor: 8.192

Review 2.  Alport syndrome--insights from basic and clinical research.

Authors:  Jenny Kruegel; Diana Rubel; Oliver Gross
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

Review 3.  Where hearing starts: the development of the mammalian cochlea.

Authors:  Martin L Basch; Rogers M Brown; Hsin-I Jen; Andrew K Groves
Journal:  J Anat       Date:  2015-06-05       Impact factor: 2.610

4.  The inner ear of dogs with X-linked nephritis provides clues to the pathogenesis of hearing loss in X-linked Alport syndrome.

Authors:  S J Harvey; R Mount; Y Sado; I Naito; Y Ninomiya; R Harrison; B Jefferson; R Jacobs; P S Thorner
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

Review 5.  Familial hematurias: what we know and what we don't.

Authors:  Clifford E Kashtan
Journal:  Pediatr Nephrol       Date:  2005-04-27       Impact factor: 3.714

6.  Sequential expression of type IV collagen networks: testis as a model and relevance to spermatogenesis.

Authors:  Scott J Harvey; Julie Perry; Keqin Zheng; Dilys Chen; Yoshikazu Sado; Barbara Jefferson; Yoshifumi Ninomiya; Robert Jacobs; Billy G Hudson; Paul S Thorner
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

7.  β3-integrin is required for differentiation in OC-2 cells derived from mammalian embryonic inner ear.

Authors:  Ivan Brunetta; Stefano O Casalotti; Ian R Hart; Andrew Forge; Louise E Reynolds
Journal:  BMC Cell Biol       Date:  2012-03-17       Impact factor: 4.241

8.  Postnatal structural development of mammalian Basilar Membrane provides anatomical basis for the maturation of tonotopic maps and frequency tuning.

Authors:  Tomomi Tani; Maki Koike-Tani; Mai Thi Tran; Michael Shribak; Snezana Levic
Journal:  Sci Rep       Date:  2021-04-07       Impact factor: 4.379

Review 9.  Revision about hearing loss in the Alport's syndrome, analyzing the clinical, genetic and bio-molecular aspects.

Authors:  Fátima R A Alves; Fernando de A Quintanilha Ribeiro
Journal:  Braz J Otorhinolaryngol       Date:  2005 Nov-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.